|By PR Newswire||
|February 10, 2014 03:01 AM EST||
DUBLIN, February 10, 2014 /PRNewswire/ --
Research and Markets (http://www.researchandmarkets.com/research/qvh485/microfluidics) has announced the addition of the "Microfluidics Market By Materials, Pharmaceuticals, Drug Delivery Devices, IVD - Global Trends & Forecast to 2018" report to their offering.
The microfluidics market is segmented based on materials, products, and applications. This report studies market trends for the above mentioned segments in three industries, namely, pharmaceutical, in-vitro diagnostics, and drug delivery devices. The market is expected to grow at a strong CAGR during the study period. This is due to factors such as the rising demand for POC devices, quick return on investments provided by microfluidics devices which helps in cost reductions, and miniaturization of microfluidic chips. However, factors such as difficulty in incorporation of emerging microfluidic technologies into existing workflows and complex and time consuming regulatory standards are hampering the growth of this market.
The estimated value of the market was calculated based on the materials, (industry) products, and applications revenue. Based on materials, the market is classified into polymers, silicon, glass, and other materials. Based on industry, the market is classified into pharmaceutical, in-vitro diagnostics, and drug delivery devices. The pharmaceutical segment is categorized into microfluidics chips for lab analytics, accurate dispensing devices, and microreactors for drug synthesis. The microfluidics chips for lab analytics segment is further classified into toxicity screening, proteomic analysis, gene sequencing, and capillary electrophoresis. In-vitro diagnostics is further segmented into clinical diagnostics, Point-of-Care diagnostics, environmental testing, industrial testing, and agro food testing. The drug delivery devices market is categorized into inhaler nozzles, micro needles, and micro pumps.
Based on applications, the market is categorized into six applications, namely, drug delivery, industrial and environmental, analytical devices, pharmaceutical and life science research, Point-of-Care diagnostics, and clinical and veterinary diagnostics. The Point-of-Care diagnostics segment commands the largest share of the global applications market. It is expected to grow at a strong CAGR during the study period. The large share of this segment is attributed to the increased adoption of microfluidics in Point-of-Care diagnostics by major diagnostic companies such as Roche Diagnostics (Switzerland), Becton Dickinson and Company (U.S.), Abbott Laboratories (U.S.), and Cepheid (U.S.).
North America dominates the market, accounting for around one-third of the share. The leading market share of the North American region is attributed to the presence of a large number of major manufacturers such as, Abbott Laboratories, Agilent Technologies, Caliper Life Sciences (PerkinElmer), and Johnson & Johnson, in this region. Additionally, the rising adoption of microfluidics technology and the increasing rate of new product launches in the North American region are the favorable factors driving the market growth.
Key Topics Covered:
2 Executive Summary
3 Premium Insights
4 Market Overview
5 Microfluidics Market, By Material
6 Microfluidic Devices Market, By Industry
7 Microfluidics Devices Market, By Applications
8 Competitive Landscape
9 Company Profiles
- Abbott Laboratories, Inc.
- Agilent Technologies
- Bartels Mikrotechnik Gmbh
- Becton, Dickinson And Company 1 Becton Drive
- Bio-Rad Laboratories, Inc.
- Biofluidix Gmbh
- Cepheid, Inc.
- Danaher Corporation
- Fluidigm Corporation
- Johnson & Johnson
- Life Technologies Corporation
- Microfluidic Chipshop Gmbh
- Perkinelmer, Inc.
- Raindance Technologies
- Roche Diagnostics Limited
- Scienion Ag
- Siemens Healthcare
For more information visit http://www.researchandmarkets.com/research/qvh485/microfluidics
Media Contact: Laura Wood, +353-1-481-1716, [email protected]
SOURCE Research and Markets